NCT05172947View on ClinicalTrials.gov

Effect of Resveratrol and Pharmacist Intervention on Diabetes Mellitus and Its Neuropathic Complication

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 5, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

December 15, 2022

Conditions
Diabetic Neuropathies
Interventions
DRUG

Resveratrol

This group received resveratrol with the conventional therapy

DRUG

Placebo

This group received placebo with the conventional therapy

OTHER

Resveratrol plus Pharmaceutical care

This group received Resveratrol with Pharmaceutical care in addition to the conventional therapy

OTHER

Placebo+Pharmaceutical care

This group received placebo with Pharmaceutical care in addition to the conventional therapy

Trial Locations (1)

00964

College of Pharmacy-University of Sulaimani, Sulaymānīyah

All Listed Sponsors
lead

University of Sulaimani

OTHER

NCT05172947 - Effect of Resveratrol and Pharmacist Intervention on Diabetes Mellitus and Its Neuropathic Complication | Biotech Hunter | Biotech Hunter